At the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, SiBionics' integrated CGM + CKM diabetes management solution received strong recognition from leading researchers worldwide. The company's symposium, themed "CGM + CKM for Better Diabetes Management," brought together international experts to share the latest scientific evidence with SiBionics' innovative approach, sparking lively discussion and broad endorsement for its potential to reshape diabetes care.
The conference was honoured to have Prof. Linong Ji from Peking University People's Hospital and Prof. Stefano Genovese from Italy serve as co-chairs. It also invited Prof. Andrej Janež (Slovenia), Prof. Nina Jendrike (Germany) and Dr Yifei Mo (China) as speakers, who shared the latest academic research findings with attending scholars.
On the exhibition floor, SiBionics' next-generation devices, the GS3 Continuous Glucose Monitoring (CGM) system and the KS3 Continuous Ketone Monitoring (CKM) device, became focal points, drawing considerable attention from attendees. Visitors expressed strong interest in the products' technical strengths and clinical relevance, engaging in active dialogue with the SiBionics team about their advantages in real-world diabetes management.
Importantly, a feasibility study has confirmed that it has met and even exceeded the iCGM standards in multiple key performance indicators. Recognised for their high accuracy and clinical reliability. The GS3 system demonstrated exceptional performance, particularly in the hypoglycemic range, surpassing iCGM requirements and reinforcing its value in supporting both clinical decision-making and patient self-management.
